Syncom Formulations Ltd.

BSE: 524470 | NSE: SYNCOMF |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE312C01025 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Syncom Formula Syncom Formulations Ltd. | BSE 13.00 -0.52 (-3.85%) | NSE 12.99 -0.50 (-3.71%) | Trade | Add

BSE Live

Feb 02, 16:01

13.00 -0.52 (-3.85%)

Volume

AVERAGE VOLUME

5-Day

214,545

10-Day

221,585

30-Day

201,218

288,678

NSE Live

Feb 02, 15:59

12.99 -0.50 (-3.71%)

Volume

AVERAGE VOLUME

5-Day

2,040,814

10-Day

2,002,846

30-Day

1,611,459

2,438,348

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Syncom Formulations (in Rs. Cr.)	Mar 05	Mar 04
Per Share Ratios
Basic EPS (Rs.)	10.71	5.93
Diluted EPS (Rs.)	10.71	5.93
Cash EPS (Rs.)	12.31	7.46
Book Value [ExclRevalReserve]/Share (Rs.)	42.06	30.08
Book Value [InclRevalReserve]/Share (Rs.)	42.06	30.08
Dividend / Share(Rs.)	1.50	1.00
Revenue from Operations/Share (Rs.)	104.59	87.76
PBDIT/Share (Rs.)	19.80	10.96
PBIT/Share (Rs.)	18.41	9.65
PBT/Share (Rs.)	17.14	7.78
Net Profit/Share (Rs.)	10.71	5.93
Profitability Ratios
PBDIT Margin (%)	18.92	12.49
PBIT Margin (%)	17.59	10.99
PBT Margin (%)	16.39	8.86
Net Profit Margin (%)	10.23	6.75
Return on Networth / Equity (%)	25.46	19.70
Return on Capital Employed (%)	19.27	12.85
Return on Assets (%)	13.31	7.99
Total Debt/Equity (X)	0.21	0.77
Asset Turnover Ratio (%)	130.00	118.34
Liquidity Ratios
Current Ratio (X)	1.95	1.57
Quick Ratio (X)	1.55	1.27
Inventory Turnover Ratio (X)	10.33	10.31
Dividend Payout Ratio (NP) (%)	14.00	16.87
Dividend Payout Ratio (CP) (%)	12.18	13.40
Earnings Retention Ratio (%)	86.00	83.13
Cash Earnings Retention Ratio (%)	87.82	86.60
Valuation Ratios
Enterprise Value (Cr.)	46.51	28.98
EV/Net Operating Revenue (X)	0.83	0.65
EV/EBITDA (X)	4.40	5.21
MarketCap/Net Operating Revenue (X)	0.75	0.39
Retention Ratios (%)	85.99	83.12
Price/BV (X)	1.87	1.14
Price/Net Operating Revenue	0.75	0.39
Earnings Yield	0.14	0.17